Latest Healthcare Research Reports

Tag: human growth hormone market trends

  • Global Human Growth Hormone Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Global Human Growth Hormone Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Human Growth Hormone Market from 2024 to 2033?
    The human growth hormone market is expected to rise from $4.33 billion in 2023 to $4.75 billion in 2024, with a CAGR of 9.8%. Contributing factors include the rising prevalence of growth disorders, increased awareness of hormone therapies, expanding uses in sports medicine, an aging population, and improved healthcare infrastructure.

    The human growth hormone market is expected to experience solid growth, projected to reach $6.93 billion by 2028 with a CAGR of 9.9%. Growth drivers include personalized medicine emergence, rising global healthcare expenditure, increased recombinant DNA technology adoption, growing demand for hormone replacement therapies, and a rise in endocrine disorders. Trends include distribution network expansion in emerging markets, AI integration in drug development, sustainable manufacturing focus, long-acting formulation development, and combination therapy utilization.

    Claim Your Free Sample of the Global Human Growth Hormone Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

    What Key Factors Are Fueling the Growth of the Human Growth Hormone Market?
    The increasing awareness of treatment procedures is anticipated to enhance growth in the human growth hormone (HGH) market. This awareness stems from advancements in medical technology and increased public interest in health. HGH treatments have gained attention for their benefits, which has raised awareness of various treatment options. According to the Substance Abuse and Mental Health Services Administration, the percentage of adolescents receiving treatment for depression increased from 40.6% in 2021 to 56.8% in 2022. Therefore, heightened awareness of treatment procedures is fostering growth in the HGH market.

    What Are the Major Segments of the Human Growth Hormone Market?
    1) By Product: Liquid, Powder
    2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands
    3) By Route Of Administration: Oral, Intravenous, Intramuscular, Subcutaneous
    4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy
    5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications

    What New Trends Are Transforming the Human Growth Hormone Market?
    Companies in the human growth hormone market are focusing on drug development to enhance treatment options. In June 2023, Pfizer Inc. and OPKO Health Inc. announced the FDA approval of NGENLA, which allows for once-weekly injections for children with growth hormone deficiency, improving adherence and treatment convenience.

    Order Now for Fast Delivery of Your Human Growth Hormone Market Report!
    https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

    Which Regions Are Driving Growth in the Human Growth Hormone Market?
    North America was the largest region in the human growth hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Human Growth Hormone Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the human growth hormone market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Human Growth Hormone Market Include

    1. Human Growth Hormone Market Executive Summary
    2. Human Growth Hormone Market Segments
    3. Human Growth Hormone Market Size And Template Market Growth Rate
    4.  Key Human Growth Hormone Market Trends
    5. Major Human Growth Hormone Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Human Growth Hormone Market
    26. Top Human Growth Hormone Companies
    27. Human Growth Hormone Market Opportunities And Strategies
    28. Human Growth Hormone Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Biosimilar Growth Hormones Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

    Parathyroid Hormone Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

    Global Biosimilar Hormones Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

    Learn More About The Business Research Company
    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
    Found this article helpful? Share it on:

  • How Is The Influenza Treatment Market Expected To Grow Through 2024-2033

    How Is The Influenza Treatment Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Influenza Treatment Global Market Report 2024, the influenza treatment market is expected to show promising growth in the forecast period.

    The influenza treatment market has experienced steady growth in recent years, with significant expansion expected in the coming years. Here’s a look at the key factors driving this growth and the major trends shaping the market.

    Current Market Size and Growth

    • 2023 Market Size: The influenza treatment market was valued at $6.34 billion in 2023.
    • 2024 Projection: It is projected to grow to $6.60 billion in 2024, reflecting a compound annual growth rate (CAGR) of 4.2%.
    • Growth Drivers: The market’s expansion is fueled by a rise in influenza cases, increased government funding for research, public awareness campaigns promoting vaccination, global influenza surveillance systems, and improved healthcare facilities.

    Future Market Outlook

    • 2028 Projection: The market is expected to grow to $7.83 billion by 2028, with a CAGR of 4.4%.
    • Contributing Factors: This growth is anticipated due to the introduction of new antiviral drugs, expanded vaccination programs, an increasing elderly population, and advancements in healthcare infrastructure and treatment options.

    View More On The Influenza Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

    Rising Prevalence of Contagious Respirato
    ry Illnesses

    • Influenza and Other Illnesses: Contagious respiratory illnesses like influenza, RSV, and measles are on the rise, driving demand for treatments.
    • Market Impact: The increase in these illnesses, due to factors like higher population densities, inadequate healthcare infrastructure, and international travel, is boosting the influenza treatment market.
    • CDC Data: For example, in September 2023, the Centers for Disease Control and Prevention (CDC) reported a significant rise in RSV hospitalizations, highlighting the need for effective influenza and respiratory illness treatments.

    Major Companies and Innovations

    • Leading Companies: Some key players in the influenza treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, and GlaxoSmithKline Plc.
    • Single-Dose Oral Medicines: Companies are focusing on expanding their product offerings with innovative treatments like single-dose oral medicines, which enhance patient compliance and improve treatment outcomes.
      • Genentech’s Xofluza: In August 2022, Genentech Inc. received FDA approval for Xofluza, the first single-dose oral medicine for treating uncomplicated influenza in children.

    Strategic Acquisitions and Market Expansion

    • Pfizer and ReViral: In June 2022, Pfizer Inc. acquired ReViral, a UK-based biotechnology company specializing in therapies for viral diseases. This acquisition aims to expand Pfizer’s RSV treatment portfolio with innovative therapies like Sisunatovir, an orally administered RSV inhibitor.

    Market Segmentation and Regional Insights

    • Product Type: The market includes products like Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, and other treatments.
    • Route of Administration: Treatments are administered orally or through other routes, depending on the product.
    • Distribution Channels: These include retail pharmacies, hospital pharmacies, and other distribution channels.
    • Regional Performance: North America was the largest region in the influenza treatment market in 2023. The Asia-Pacific region is expected to be the fastest-growing market in the forecast period, driven by improvements in healthcare infrastructure and increased awareness of influenza treatments.

    Conclusion
    The influenza treatment market is poised for significant growth in the coming years, driven by rising rates of respiratory illnesses, innovations in treatment options, and strategic acquisitions by major pharmaceutical companies. With continued advancements in healthcare and increasing awareness of the importance of influenza prevention and treatment, the market is set to expand steadily, offering new opportunities for stakeholders across the globe.

    Request A Sample Of The Global Influenza Treatment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15832&type=smp

  • Global Human Growth Hormone Market Key Insights 2024-2033

    Global Human Growth Hormone Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Human Growth Hormone Global Market Report 2024, the human growth hormone market is expected to show promising growth in the forecast period.

    Significant Market Growth in Recent Years

    • Market Expansion: The human growth hormone (HGH) market has experienced robust growth in recent years, expanding from $4.33 billion in 2023 to an estimated $4.75 billion in 2024.
    • Growth Drivers: This growth is driven by the increasing prevalence of growth disorders, rising awareness about hormone therapies, expanding applications in sports medicine, and a growing geriatric population. Improvements in healthcare infrastructure have also contributed to this upward trend.

    Projected Growth and Key Factors for the Future

    • Continued Expansion: The HGH market is projected to reach $6.93 billion by 2028, growing at a compound annual growth rate (CAGR) of 9.9%.
    • Future Drivers: Key factors expected to fuel this growth include the emergence of personalized medicine, rising healthcare expenditures, the increasing adoption of recombinant DNA technology, and the growing demand for hormone replacement therapies. Additionally, the rising prevalence of endocrine disorders is anticipated to boost market demand.

    View More On The Human Growth Hormone Market Report 2024 – https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

    Trends Shaping the Future of HGH Market

    • Emerging Trends: The HGH market is witnessing several significant trends. These include the expansion of distribution networks in emerging markets and the integration of artificial intelligence in drug development.
    • Innovations: There is also a growing emphasis on sustainable manufacturing processes, the development of long-acting formulations, and the utilization of combination therapies for enhanced efficacy.

    Increased Awareness of Treatment Procedures

    • Rising Awareness: The increasing awareness of treatment procedures, driven by advancements in medical technology and greater access to information, is propelling the growth of the HGH market.
    • Impact: Media coverage and public interest in health and wellness have highlighted the benefits of HGH treatments, increasing awareness and acceptance of hormone therapies.

    Leading Companies in the HGH Market

    • Key Players: Major companies operating in the HGH market include Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, and Teva Pharmaceutical Industries Ltd., among others.
    • Market Dynamics: These companies are actively engaged in advancing drug development, expanding their product portfolios, and enhancing patient care.

    Innovation in Treatment Options

    • FDA Approvals: Innovations in HGH treatments have led to new approvals by regulatory bodies. For instance, Pfizer Inc. and OPKO Health Inc. received FDA approval for NGENLA (somatrogon-ghla) in June 2023.
    • Benefits: This new treatment provides a more convenient dosing regimen, allowing for weekly rather than daily injections, improving patient adherence and overall treatment outcomes.

    Digital Health Solutions in Growth Disorders Management

    • Partnerships for Advancement: In April 2021, Merck KGaA partnered with PRA Health Science to enhance the management of growth hormone therapy through digital health solutions.
    • Improved Care: This partnership focuses on providing a more personalized and effective approach to patient care, utilizing remote patient monitoring and other digital tools.

    Market Segmentation and Regional Insights

    • Product Segments: The HGH market is segmented by product (liquid, powder), brand (Norditropin, Genotropin, Humatrope, etc.), route of administration (oral, intravenous, etc.), distribution channel (hospital pharmacies, retail pharmacies, etc.), and application (growth hormone deficiency, Turner syndrome, etc.).
    • Regional Outlook: North America was the largest region in the HGH market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period, driven by increasing healthcare investments and rising awareness.

    The human growth hormone market continues to evolve, driven by technological advancements, growing demand for innovative therapies, and expanding global reach. With ongoing research and development, the future looks promising for both patients and providers in this dynamic field.

    Request A Sample Of The Global Human Growth Hormone Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15825&type=smp